bit.bio CEO Mark Kotter is featured as part of the Disruptor series from Charles River Laboratories (CRL). The series, created by CRL, celebrates the work of their partners, engaging in meaningful conversation about the current state of human health and future of scientific innovation and its impact.
Mark discusses bit.bio's software approach to biology and how human cells that are programmed like computers can impact research, drug discovery and cell therapies.
Watch the full Disruptor series on the CRL website.